Gender | Female | 31 (48.5%) |
---|---|---|
Male | 33 (51.5%) | |
Unknown | 1 | |
Age | Mean | 42.84 years (range from 25 to 71) |
Median | 42 years | |
Countries of origin | West Africa | 29 (63%) |
Ghana | 8 | |
Ivory Coast | 7 | |
Cape Verde Islands | 5 | |
Guinea-Bissau | 3 | |
Guinea | 2 | |
Senegal | 1 | |
Liberia | 1 | |
Nigeria | 1 | |
Burkina-Faso | 1 | |
Europe | 11 (24%) | |
Belgium | 6 | |
Portugal | 5 | |
Central and Southern Africa | 4 (8.5%) | |
Democratic Republic Congo | 3 | |
South-Africa | 1 | |
Asia: Nepal | 2 (4%) | |
Not documented | 19 | |
Transmission | Heterosexual | 37 (86%) |
Homosexual (MSM) | 2 (4.5%) | |
Intra-venous drug use | 2 (4.5%) | |
Transfusion | 2 (4.5%) | |
Not documented | 22 | |
Year of infection | Between 2002 and 2006 | 10 (33%) |
Between 1997 and 2001 | 7 (23%) | |
Before 1997 | 13 (43%) | |
Not documented | 22 | |
ARV use | Treated | 20 (31%) |
Exposed to NRTIs only | 5 | |
Exposed to NRTIs and PIs | 15 | |
Treated at the end of 2006 | 15 | |
Never been treated | 45 (69%) | |
Subtype | A | 25 (83%) |
B | 5 (17%) | |
Not documented | 35 |